Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
WuXi PharmaTech has strengthened its...
WuXi PharmaTech acquired XenoBiotic...
WuXi PharmaTech, the China CRO with...
WuXi PharmaTech reported Q3 revenues...
WuXi PharmaTech, China's largest...
WuXi PharmaTech filed to list SynTheAll...
With the end of 2014 almost here, WuXi...
To make life easier for its CRO clients,...
WuXi PharmaTech, the China-US CRO/CMO,...
WuXi PharmaTech paid $65 million in cash...
Upcoming Events
BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here
Register here
Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events
Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here